Rituximab Imports from UNITED STATES to India — Trade Data & Analysis

Name: UNITED STATES to India Rituximab Bilateral Import Data — 8 Suppliers, 9 Buyers, $15.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

TransData Nexus

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Rituximab Imports from UNITED STATES to India (2026) — $15.6K USD, 18 Shipments, Top Suppliers | TransData Nexus | TransData Nexus

Who Supplies Rituximab to India from UNITED STATES

India's rituximab imports from UNITED STATES total $15.6K across 18 shipments from 8 foreign suppliers. CELTIS HEALTHCARE LLC leads with $11.5K in import value; the top 5 suppliers together control 97.1% of this origin. Leading Indian buyers include CURATEQ BIOLOGICS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for rituximab — a diversified sourcing base with multiple active suppliers from UNITED STATES.

Source: Indian Customs (DGFT) Import Records · TransData NexusUpdated February 2026

Top foreign suppliers (UNITED STATES) — Ranked by import value

CELTIS HEALTHCARE LLC is the leading Rituximab supplier from UNITED STATES to India, with import value of $11.5K across 4 shipments. The top 5 suppliers — CELTIS HEALTHCARE LLC, KREATIVE TECHNOLABS, BIO-RAD ABD SEROTEC LTD,, BIO-RAD ABD SEROTEC LIMITED, R D SYSTEMS, INC. — collectively account for 97.1% of total import value from this origin.

Top foreign suppliers (UNITED STATES)

Ranked by import value (USD) · Indian Customs (DGFT) data

Feb 2026

Top Rituximab suppliers from UNITED STATES to India — ranked by import value (USD). 8 suppliers. Indian Customs (DGFT) data compiled by TransData Nexus.
#	Supplier	Value (USD)	Shipments	Share
1	CELTIS HEALTHCARE LLC	$11.5K	4	73.5%

Top Indian buyers (importing from UNITED STATES)

Ranked by import value (USD)

Top Indian buyers of Rituximab from UNITED STATES — ranked by import value
#	Buyer	Value (USD)	Shipments	Share
1	CURATEQ BIOLOGICS PRIVATE LIMITED	$8.0K	2	51.0%
2	IPCA LABORATORIES LIMITED	$2.4K	1	15.3%
3	KRISHGEN BIOSYSTEMS	$2.3K	3	14.8%
4	ZYDUS LIFESCIENCES LIMITED	$1.1K	1	7.2%
5	BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED	$516	6	3.3%
6	BIO RAD LABORATORIES I PRIVATE LIMITED	$475	1	3.0%
7	INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED	$441	2	2.8%
8	AGILE DIAGNOSTICS	$389	1	2.5%
9	KASHIV BIOSCIENCES PRIVATE LIMITED	$15	1	0.1%

Frequently Asked Questions — Rituximab Imports from UNITED STATES

Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus

QWho are the top Rituximab suppliers from UNITED STATES to India?

The top Rituximab suppliers from UNITED STATES to India include CELTIS HEALTHCARE LLC, KREATIVE TECHNOLABS, BIO-RAD ABD SEROTEC LTD,. The leading supplier is CELTIS HEALTHCARE LLC with import value of $11.5K USD across 4 shipments. India imported Rituximab worth $15.6K USD from UNITED STATES in total across 18 shipments.

QHow much Rituximab does India import from UNITED STATES?

India imported Rituximab worth $15.6K USD from UNITED STATES across 18 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.

QWho are the main Indian buyers of Rituximab from UNITED STATES?

The main Indian buyers of Rituximab sourced from UNITED STATES include CURATEQ BIOLOGICS PRIVATE LIMITED, IPCA LABORATORIES LIMITED, KRISHGEN BIOSYSTEMS. The largest buyer is CURATEQ BIOLOGICS PRIVATE LIMITED with $8.0K in imports across 2 shipments.

QWhat is the total value of Rituximab imports from UNITED STATES to India?

The total value of Rituximab imports from UNITED STATES to India is $15.6K USD, across 18 shipments and 8 foreign suppliers. Data source: Indian Customs (DGFT).

Official References & Regulatory Resources

Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rituximab

Rituximab

Who Supplies Rituximab to India from UNITED STATES

Top foreign suppliers (UNITED STATES) — Ranked by import value

Top foreign suppliers (UNITED STATES)

Top Indian buyers (importing from UNITED STATES)

Import Statistics

Other Rituximab Import Origins

Related Analysis

Need Details?

Frequently Asked Questions — Rituximab Imports from UNITED STATES

QWho are the top Rituximab suppliers from UNITED STATES to India?

QHow much Rituximab does India import from UNITED STATES?

QWho are the main Indian buyers of Rituximab from UNITED STATES?

QWhat is the total value of Rituximab imports from UNITED STATES to India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology